NorthWest Biotherapeutics Inc (NWBO)

[eagle8]

dstock,
You posted :

"I keep mentioning to EX and Hygro that real world data/evidence from two or three hundreds of patients are far more for RA to grant approval, not to mention GBM is one of the top ten rarest cancer with no effective treatment ".

According to Dr.Bosch presentation :

"And we have used it to date to treat almost 600 patients with GBM, both in clinical trials, and in compassionate use programs, and also tens of patients with other cancers, including: Merkel cell carcinoma, breast cancer, thyroid cancer, and several others. The trial results from the phase 3 trial have now been published in JAMA Oncology, with Dr Linda Liau from UCLA, as the first author, showing both clinically meaningful, and statistically significant, extension of survival, in both newly diagnosed, and recurrent GBM"

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172268765

GLTU

.